Hu, Bi <br/><br/>
Bioactivity, pharmacokinetics, and immunogenicity assays in preclinical and clinical trials for recombinant human endostatin.  [electronic resource] 

 -  Acta pharmacologica Sinica  Nov 2008 
 - 1357-69 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1745-7254 
<br/><br/><label>Standard No.: </label>10.1111/j.1745-7254.2008.00865.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--immunology<br/>Animals<br/>Antineoplastic Agents--immunology<br/>Endostatins--immunology<br/>Endothelial Cells--drug effects<br/>Female<br/>Humans<br/>Macaca mulatta<br/>Male<br/>Mice<br/>Recombinant Proteins--immunology<br/>Sex Characteristics<br/>Tetrazolium Salts<br/>Thiazoles